重大事件
即時報告
8-K
2026-06-09
LB Pharmaceuticals Inc. 提交8-K報告，披露股東大會表決事項
AI 繁中摘要
📄 LB Pharmaceuticals Inc. (CIK: 0001691082) 於2026年6月9日向SEC提交了一份8-K表格，報告期為2026年6月3日。該申報屬於Item 5.07（提交事項供證券持有人表決），意味著公司當日舉行了股東大會並進行了投票。由於文件僅提供基本元數據，未披露具體投票結果或議案細節，投資者需密切留意後續補充文件或官方公告。作為一家專注於藥物製劑的臨床階段生物製藥公司（SIC 2834），任何股東表決事項（如董事選舉、高管薪酬、重大交易批准等）均可能影響公司治理及未來發展方向。建議投資者查閱完整申報文本（Accession No. 0001193125-26-263724）以獲取表決結果明細，從而評估對股權結構或戰略執行的潛在影響。🔍
展開英文正文
EDGAR Filing Documents for 0001193125-26-263724 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-263724 Filing Date 2026-06-09 Accepted 2026-06-09 16:05:22 Documents 11 Period of Report 2026-06-03 Items Item 5.07: Submission of Matters to a Vote of Security Holders Interactive Data Document Format Files Seq Description Document Type Size 1 8-K d138757d8k.htm iXBRL 8-K 28426 Complete submission text file 0001193125-26-263724.txt 147011 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA lbrx-20260603.xsd EX-101.SCH 3182 3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lbrx-20260603_lab.xml EX-101.LAB 18734 4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lbrx-20260603_pre.xml EX-101.PRE 11708 14 EXTRACTED XBRL INSTANCE DOCUMENT d138757d8k_htm.xml XML 3772 Mailing Address 575 MADISON AVENUE NEW YORK NY 10022 Business Address 575 MADISON AVENUE NEW YORK NY 10022 917-450-6581 LB PHARMACEUTICALS INC (Filer) CIK: 0001691082 (see all company filings) EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-42831 | Film No.: 261076079 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)